- 专利标题： PYRIDINE-SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITORS
-
申请号： EP15826817申请日： 2015-07-31
-
公开(公告)号： EP3176160A4公开(公告)日： 2017-12-06
- 发明人: GONG FENG , LI XINLU , ZHAO RUI , ZHANG XIQUAN , XU XINHE , LIU XIJIE , XIAO DENGMING , HAN YONGXIN
- 申请人： CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD , LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD , CENTAURUS BIOPHARMA CO LTD
- 专利权人： CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD,LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD,CENTAURUS BIOPHARMA CO LTD
- 当前专利权人： CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD,LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD,CENTAURUS BIOPHARMA CO LTD
- 优先权： CN201410371344 2014-07-31
- 主分类号： C07D401/14
- IPC分类号： C07D401/14 ; A61K31/444 ; A61K31/496 ; A61P35/00 ; C07D213/73
摘要：
The present invention discloses pharmaceutically acceptable acid salts of pyridine-substituted 2-aminopyridine derivatives as protein kinase inhibitors, preparation methods, pharmaceutical compositions thereof, and use thereof for the treatment of diseases associated with protein kinase.
信息查询
